Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
about
Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsKDM1 class flavin-dependent protein lysine demethylasesNew targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersIntegrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.The correlation between DNMT1 and ERα expression and the methylation status of ERα, and its clinical significance in breast cancerKDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.Silencing DNA methyltransferase 1 leads to the activation of the esophageal suppressor gene p16 in vitro and in vivo.MAP Kinase-Dependent RUNX2 Phosphorylation Is Necessary for Epigenetic Modification of Chromatin During Osteoblast Differentiation.Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression.Targeting LSD2 in breast cancer.HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
P2860
Q26781745-FBFE2C64-5314-48A5-849A-D7C9C6BD6AC1Q28084876-8511D50C-7575-437B-A17C-75DDEFA7CFD1Q34706060-8B7D512B-3100-4D37-BD86-7E6E0226D7E7Q36495170-50E5AAA0-3ED2-46A4-97C9-C05AB3347F41Q36640701-F3EC2A85-1ED3-4B42-A3A5-6C6530F955D6Q38537765-EC5E2CA1-D99B-46F9-BAFF-DAAE3A46BB51Q38769263-69727C51-682B-401F-8B20-5587F60BC73FQ41614123-211A51BB-2E42-4D0B-9FFB-6EE25D819B9CQ42808199-7A037ED5-CFEE-4F2D-8CDE-6A131A599745Q47141052-0AC07AEC-C36F-4BBC-B9B8-8D60F7BF2147Q50196841-634C90EC-17D5-4733-9BFB-6A0EBE4A97F4Q52597230-6B557F95-445C-4807-8089-A8133157401DQ55310228-567E73CB-F763-4261-818A-1181D5CDAF99
P2860
Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Inhibition of histone demethyl ...... ptosis in breast cancer cells.
@en
type
label
Inhibition of histone demethyl ...... ptosis in breast cancer cells.
@en
prefLabel
Inhibition of histone demethyl ...... ptosis in breast cancer cells.
@en
P2093
P2860
P1476
Inhibition of histone demethyl ...... ptosis in breast cancer cells.
@en
P2093
Emily Harrington
Nancy E Davidson
Shauna N Vasilatos
Steffi Oesterreich
Tiffany A Katz
P2860
P2888
P304
P356
10.1007/S10549-014-3012-9
P407
P50
P577
2014-06-13T00:00:00Z
P5875
P6179
1043385509